| 0 |
Interleukin-5 Antagonist [EPC] |
1 |
0.0015 |
| 1 |
Chemokine Receptor Type 4 Interaction [EPC] |
1 |
0.0007 |
| 2 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
8 |
0.0004 |
| 3 |
Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] |
1 |
0.0002 |
| 4 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
13 |
0.0001 |
| 5 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
3 |
0.0001 |
| 6 |
CTLA-4-directed Blocking Antibody [EPC] |
5 |
0.0001 |
| 7 |
CD19-directed Chimeric Antigen Receptor [EPC] |
1 |
0.0001 |
| 8 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
9 |
0.0001 |
| 9 |
Protease Inhibitor [EPC] |
3 |
0.0001 |
| 10 |
BCL-2 Inhibitor [EPC] |
4 |
0.0001 |
| 11 |
CD52-directed Cytolytic Antibody [EPC] |
1 |
0.0001 |
| 12 |
Azole Antifungal [EPC] |
8 |
0.0001 |
| 13 |
Cytochrome P450 3A Inhibitor [EPC] |
3 |
0.0000 |
| 14 |
Platinum-based Drug [EPC] |
12 |
0.0000 |
| 15 |
Microtubule Inhibitor [EPC] |
6 |
0.0000 |
| 16 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
3 |
0.0000 |
| 17 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
3 |
0.0000 |
| 18 |
Corticosteroid [EPC] |
29 |
0.0000 |
| 19 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
3 |
0.0000 |
| 20 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
4 |
0.0000 |
| 21 |
Calcium [EPC] |
2 |
0.0000 |
| 22 |
Topoisomerase Inhibitor [EPC] |
1 |
0.0000 |
| 23 |
Catecholamine [EPC] |
1 |
0.0000 |
| 24 |
Anti-IgE [EPC] |
1 |
0.0000 |
| 25 |
Prostaglandin Analog [EPC] |
1 |
0.0000 |
| 26 |
HMG-CoA Reductase Inhibitor [EPC] |
4 |
0.0000 |
| 27 |
Proton Pump Inhibitor [EPC] |
6 |
0.0000 |
| 28 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
1 |
0.0000 |
| 29 |
Opioid Agonist [EPC] |
2 |
0.0000 |
| 30 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 31 |
Dihydropyridine Calcium Channel Blocker [EPC] |
2 |
0.0000 |
| 32 |
Xanthine Oxidase Inhibitor [EPC] |
1 |
0.0000 |
| 33 |
Platelet Aggregation Inhibitor [EPC] |
3 |
0.0000 |
| 34 |
Folate Analog Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 35 |
Alkylating Drug [EPC] |
1 |
0.0000 |
| 36 |
Retinoid [EPC] |
1 |
0.0000 |
| 37 |
Factor Xa Inhibitor [EPC] |
1 |
0.0000 |
| 38 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 39 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 40 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 41 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
3 |
0.0000 |